Atlas Trials

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

Clinical trial NCT07365839 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07365839
Sponsor
Virginia Commonwealth University
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2026-07-01
Primary completion
2035-02-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.